CAD 0.34
(1.49%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -8.74 Million CAD | 54.21% |
2022 | -17.21 Million CAD | -2.65% |
2021 | -16.77 Million CAD | 48.95% |
2020 | -32.86 Million CAD | -47.94% |
2019 | -22.21 Million CAD | -212.9% |
2018 | -7.09 Million CAD | -173.09% |
2017 | -2.59 Million CAD | -8614.03% |
2016 | -29.83 Thousand CAD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -788.68 Thousand CAD | 69.4% |
2024 Q2 | -1.75 Million CAD | -146.64% |
2023 Q4 | -2.57 Million CAD | -80.96% |
2023 FY | -7.88 Million CAD | 54.21% |
2023 Q3 | -1.42 Million CAD | 19.05% |
2023 Q2 | -1.75 Million CAD | 28.92% |
2023 Q1 | -2.47 Million CAD | 66.99% |
2022 Q1 | -898.62 Thousand CAD | 89.08% |
2022 FY | -17.21 Million CAD | -2.65% |
2022 Q4 | -7.49 Million CAD | -158.38% |
2022 Q3 | -2.9 Million CAD | 51.01% |
2022 Q2 | -5.92 Million CAD | -559.04% |
2021 Q2 | -2.76 Million CAD | 10.74% |
2021 FY | -16.77 Million CAD | 48.95% |
2021 Q1 | -3.1 Million CAD | 81.28% |
2021 Q4 | -8.23 Million CAD | -208.2% |
2021 Q3 | -2.67 Million CAD | 3.56% |
2020 Q3 | -6.68 Million CAD | 3.78% |
2020 Q2 | -6.94 Million CAD | -161.93% |
2020 FY | -32.86 Million CAD | -47.94% |
2020 Q1 | -2.65 Million CAD | 60.48% |
2020 Q4 | -16.57 Million CAD | -147.9% |
2019 Q4 | -6.71 Million CAD | -10.55% |
2019 Q3 | -6.07 Million CAD | -32.63% |
2019 FY | -22.21 Million CAD | -212.9% |
2019 Q2 | -4.57 Million CAD | -23.42% |
2019 Q1 | -3.7 Million CAD | -14.01% |
2018 Q2 | -1.46 Million CAD | -703.76% |
2018 FY | -7.09 Million CAD | -173.09% |
2018 Q4 | -3.25 Million CAD | -55.74% |
2018 Q3 | -2.08 Million CAD | -42.19% |
2018 Q1 | -182.81 Thousand CAD | 84.47% |
2017 Q4 | -1.17 Million CAD | -108.51% |
2017 FY | -2.59 Million CAD | -8614.03% |
2017 Q3 | -564.36 Thousand CAD | 0.0% |
2016 FY | -29.83 Thousand CAD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Aurora Cannabis Inc. | -69.32 Million CAD | 87.389% |
Avant Brands Inc. | -5.07 Million CAD | -72.446% |
Cardiol Therapeutics Inc. | -28.12 Million CAD | 68.917% |
Crescita Therapeutics Inc. | -1.98 Million CAD | -340.232% |
Knight Therapeutics Inc. | -16.83 Million CAD | 48.067% |
MediPharm Labs Corp. | -13.08 Million CAD | 33.173% |
OrganiGram Holdings Inc. | -229.47 Million CAD | 96.19% |
Canopy Growth Corporation | -657.26 Million CAD | 98.67% |
Willow Biosciences Inc. | -13.02 Million CAD | 32.896% |
Auxly Cannabis Group Inc. | -44.51 Million CAD | 80.358% |